£
Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2))

S
Definitive Information Statement

MEDISWIPE
INC.

(Name
of Registrant As Specified In Charter)

Payment of Filing Fee (Check
the appropriate box):

S

No fee
required.

£

Fee computed
on table below per Exchange Act Rules 14c-5(g) and 0-11.

1)

Title
of each class of securities to which transaction applies:

2)

Aggregate number of
securities to which transaction applies:

3)

Per unit price or
other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):

4)

Proposed maximum aggregate
value of transaction:

5)

Total fee paid:

£

Fee paid
previously with preliminary materials.

£

Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing.

1)

Amount
Previously Paid:

2)

Form,
Schedule or Registration Statement No:

3)

Filing
Party:

4)

Date
Filed:

(1)

THIS INFORMATION
STATEMENT IS BEING PROVIDED TO

YOU BY
THE BOARD OF DIRECTORS OF MEDISWIPE, INC.

MEDISWIPE
INC.

407
E Fort Street, Suite 510

Detroit,
MI. 48226

(248)
262-6850

INFORMATION
STATEMENT

October
22, 2013

NOTICE
OF STOCKHOLDER ACTION BY WRITTEN CONSENT

GENERAL
INFORMATION

We hereby
inform you of a decision made by holders of a majority of outstanding shares of MediSwipe, Inc. (“MediSwipe” or “Company”),
who have consented to the following actions:

1.

A
combination of the shares of common stock of the Company, or reverse stock split, such that each ten (10) shares of common
stock shall be converted into one (1) share of common stock (“Reverse Stock Split”).

2.

Authorize
the Board of Directors of the Company to decrease its authorized common stock from 500,000,000 shares, $0.0001 par value,
to 250,000,000 shares, $0.0001 par value (“Decrease in Authorized Common
Stock”).

MediSwipe
common stock currently is traded on the OTC Bulletin Board under the symbol “MWIP”. The most recent reported closing
price of MediSwipe common stock on October 22, 2013 was $0.03 per share.

The holders
of a majority of our outstanding common stock, owning approximately 52.9% of the outstanding shares of our common stock, have
executed a written consent in favor of the action described above that is described in greater detail in the Information Statement
accompanying this notice. This consent satisfies the shareholder approval requirement for the proposed action and allows us to
take the proposed action on or about November 22, 2013.

WE
ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND A PROXY.

The Board
believes that the Stockholders of the Company will benefit from the Reverse Stock Split and Decrease in Authorized Common Stock
because it believes such Reverse Stock Split could be a catalyst for an increase in the stock price of the Common Stock, which
in turn could increase the marketability and liquidity of the Company’s Common Stock. Both Reverse Stock Split and Decrease
in Authorized Common Stock could increase the profile of the Company for private investment, acquisitions and other future opportunities
that become available to the Company. We have no current plans, proposals or arrangements to engage in any corporate transactions
that would require the issuance of additional securities made available pursuant to this proposal.

Accordingly,
it is the Board’s opinion that the Actions would better position the Company to attract potential business candidates and
provide the Stockholders a greater potential return.

On behalf of the
Board of Directors,

/s/ B. Michael
Friedman

Chief Executive
Officer and Director

(2)

INTRODUCTION

Delaware
law provides that the written consent of the holders of outstanding shares of voting capital stock having not less than the minimum
number of votes which would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon
were present and voted can approve an action in lieu of conducting a special stockholders' meeting convened for the specific purpose
of such action. Delaware law, however, requires that in the event an action is approved by written consent, a company must provide
prompt notice of the taking of any corporate action without a meeting to the stockholders of record who have not consented in
writing to such action and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if
the record date for such meeting had been the date that written consents signed by a sufficient number of holders to take the
action were delivered to a company.

In accordance
with the foregoing, we will mail the Notice of Stockholder Action by Written Consent on or about November 1, 2013.

This
Information Statement contains a brief summary of the material aspects of the Actions approved by the Board of MediSwipe, Inc.,
(the “Company,” “we,” “our,” or “us”) and the Majority
Stockholder.

The Board
of Directors has recommended and the majority shareholders of MediSwipe have adopted resolutions to effect the above-listed actions.
This Information Statement is being filed with the Securities and Exchange Commission and is provided to the shareholders of the
Company pursuant to Section 14(c) of the Securities Exchange Act of 1934, as amended.

We are
a corporation organized under the laws of Delaware. We are a 1934 Act company with stock registered pursuant to Section 12(g),
quoted on the Over the Counter Bulletin Board, under the symbol “MWIP". Information about us can be found in our December
31, 2012 Annual Report filed on Form 10-K. Additional information about us can be found in our public filings that can be accessed
electronically by means of the SEC's home page on the Internet at http://www.sec.gov, or at other Internet sites such as http://www.freeedgar.com,
as well as by such other means from the offices of the SEC.

ACTIONS
TO BE TAKEN

The Reverse
Stock Split and Decrease in Authorized Common Stock will become effective on the date that we file the Certificate of Amendment
to the Articles of Incorporation of the Company (the “Amendment”) with the Secretary of State of the State
of Delaware. We intend to file the Amendment with the Secretary of State of the State of Delaware promptly after the twentieth
(20th) day following the date on which this Information Statement is mailed to the Stockholders.

We currently
expect to file the Amendment on or about November 22, 2013.

(3)

1-FOR-10
REVERSE STOCK SPLIT

GENERAL

Our Board
approved by unanimous written consent a 1-for-10 reverse stock split (the “Reverse Stock Split”). Pursuant
to the Reverse Stock Split, each ten (10) shares of our Common Stock will be automatically converted, without any further action
by the Stockholders, into one share of Common Stock. No fractional shares of Common Stock will be issued as the result of
the Reverse Stock Split. Instead, the Company will issue to the Stockholders one additional share of Common Stock for each fractional
share. The Company anticipates that the effective date of the Reverse Stock Split will be November 22, 2013.

PLEASE
NOTE THAT THE REVERSE STOCK SPLIT WILL NOT CHANGE YOUR PROPORTIONATE EQUITY INTERESTS IN THE COMPANY, EXCEPT AS MAY RESULT FROM
THE ISSUANCE OF SHARES PURSUANT TO THE FRACTIONAL SHARES.

PURPOSE
AND EFFECT OF THE REVERSE STOCK SPLIT

Our Board
believes that, among other reasons, the number of outstanding shares of Common Stock have contributed to a lack of investor interest
in the Company and has made it difficult for the Company to attract new investors and potential business candidates. Our
Board proposed the Reverse Stock Split as one method to attract business opportunities for the Company. Our Board believes that
the Reverse Stock Split could increase the stock price of our Common Stock and that the higher stock price could help generate
interest in the Company by investors and provide business opportunities. We have no current plans, proposals or arrangements
to engage in any corporate transactions that would require the issuance of additional securities made available pursuant to this
proposal.

However,
the effect of the Reverse Stock Split, if any, upon the stock price for our Common Stock cannot be predicted, and the history
of similar stock split combinations for companies like us is varied. Further, we cannot assure you that the stock price of our
Common Stock after the Reverse Stock Split will rise in proportion to the reduction in the number of shares of Common Stock outstanding
as a result of the Reverse Stock Split because, among other things, the stock price of our Common Stock may be based on our performance
and other factors as well.

The principal
effect of the Reverse Stock Split will be the reduction in the number of shares of Common Stock issued and outstanding from 448,378,661
shares as of October 9, 2013,to approximately 44,837,866 shares. The Reverse Stock Split will affect all of our Stockholders
uniformly and will not affect any Stockholder’s percentage ownership interest in the Company or proportionate voting power,
except to the extent that the Reverse Stock Split results in any of our Stockholders holding a fractional share of our Common
Stock. The Common Stock issued pursuant to the Reverse Stock Split will remain fully paid and non-assessable. The Reverse Stock
Split shall not affect any rights, privileges or obligations with respect to the shares of Common Stock existing prior to the
Reverse Stock Split, nor does it increase or decrease the market capitalization of the Company. The Reverse Stock Split is not
intended as, and will not have the effect of, a “going private transaction” under Rule 13e-3 of the Exchange Act.
We will continue to be subject to the periodic reporting requirements of the Exchange Act.

By reducing
the number of issued and outstanding shares of Common Stock, more shares of Common Stock are available for issuance as a result
of the Reverse Stock Split. The Board believes that the availability of more shares of Common Stock for issuance will allow the
Company greater flexibility in pursuing financing from investors and issuing shares of Common Stock in exchange for such financing,
meeting business needs as they arise, taking advantage of favorable opportunities, and responding to a changing corporate environment.

The following
chart depicts the capitalization structure of the Company both pre-Reverse Stock Split and post-Reverse Stock Split (the post-split
shares of Common Stock may differ slightly based on the number of fractional shares):

(4)

Pre-Reverse
Stock Split

Authorized
Shares

of
Common Stock

Issued
Shares

Authorized
but Unissued

500,000,000

448,378,661

51,621,339

Post-Reverse
Stock Split

Authorized
Shares

Issued
Shares

Authorized
but Unissued

250,000,000

44,837,866

205,162,134

CERTAIN
RISKS ASSOCIATED WITH REVERSE STOCK SPLIT

You should
recognize that you will own a lesser number of shares of Common Stock than you presently own. While we hope that the Reverse Stock
Split will result in an increase in the potential stock price of our Common Stock, we cannot assure you that the Reverse Stock
Split will increase the potential stock price of our Common Stock by a multiple equal to the inverse of the Reverse Stock Split
ratio or result in the permanent increase in any potential stock price (which is dependent upon many factors, including our performance
and prospects). Should the stock price of our Common Stock decline, the percentage decline as an absolute number and as a percentage
of our overall market capitalization may be greater than would occur in the absence of a Reverse Stock Split. Furthermore, the
possibility exists that potential liquidity in the stock price of our Common Stock could be adversely affected by the reduced
number of shares of Common Stock that would be outstanding after the Reverse Stock Split. In addition, the Reverse Stock Split
will increase the number of Stockholders of the Company who own odd lots (less than 100 shares). Stockholders who hold odd lots
typically will experience an increase in the cost of selling their shares, as well as possible greater difficulty in effecting
such sales. As a result, we cannot assure you that the Reverse Stock Split will achieve the desired results that have been outlined
above.

ANTI-TAKEOVER
EFFECTS OF THE REVERSE STOCK SPLIT

THE OVERALL
EFFECT OF THE REVERSE STOCK SPLIT MAY BE TO RENDER MORE DIFFICULT THE CONSUMMATION OF MERGERS WITH THE COMPANY OR THE ASSUMPTION
OF CONTROL BY A PRINCIPAL STOCKHOLDER, AND THUS MAKE IT DIFFICULT TO REMOVE MANAGEMENT.

A possible
effect of the Reverse Stock Split is to discourage a merger, tender offer or proxy contest, or the assumption of control by a
holder of a large block of the Company’s voting securities and the removal of incumbent management. Our management could
use the additional shares of Common Stock available for issuance to resist or frustrate a third-party take-over effort favored
by a majority of the independent Stockholders that would provide an above market premium by issuing additional shares of Common
Stock.

The Reverse
Stock Split is not the result of management’s knowledge of an effort to accumulate the Company’s securities or to
obtain control of the Company by means of a merger, tender offer, solicitation or otherwise. Nor is the Reverse Stock Split a
plan by management to adopt a series of amendments to the Company’s charter or by-laws to institute an anti-takeover provision. The
Company does not have any plans or proposals to adopt other provisions or enter into other arrangements that may have material
anti-takeover consequences. As discussed above, the reason for the Reverse Stock Split is to increase the amount of shares of
Common Stock that the Company is able to issue in order to attract potential investors and conduct equity financings.

We anticipate
that the Reverse Stock Split will become effective on November 22, 2013, or as soon thereafter as is reasonably practicable (the
“Effective Date”). Beginning on the Effective Date, each stock certificate representing pre-Reverse Stock Split
shares of Common Stock will be deemed for all corporate purposes to evidence ownership of post-Reverse Stock Split shares of Common
Stock.

Our transfer
agent, Interwest Transfer Company, Inc., will act as exchange agent (the “Exchange Agent”) for purposes of
implementing the exchange of stock certificates. Holders of pre- Reverse Stock Split shares of Common Stock are asked to surrender
to the Exchange Agent stock certificates representing pre-Reverse Stock Split shares of Common Stock in exchange for stock certificates
representing post- Reverse Stock Split shares of Common Stock. No new stock certificates will be issued to a Stockholder until
such Stockholder has surrendered the outstanding stock certificate(s) held by such Stockholder, together with a properly completed
and executed letter of transmittal.

Further,
prior to filing the amendment to the Certificate of Incorporation reflecting the Reverse Stock Split, we must first notify the
Financial Industry Regulatory Authority (“FINRA”) by filing the Issuer Company Related Action Notification
Form no later than ten (10) days prior to our anticipated record date of November 22, 2013, for the Reverse Stock Split. Our failure
to provide such notice may constitute fraud under Section 10 of the Exchange Act.

(5)

STOCKHOLDERS
SHOULD NOT DESTROY ANY STOCK CERTIFICATES AND SHOULD NOT SUBMIT ANY CERTIFICATES WITHOUT THE LETTER OF TRANSMITTAL.

FRACTIONAL
SHARES

No fractional
shares of Common Stock will be issued as the result of the Reverse Stock Split. Instead, the Company will issue to the Stockholders
one additional share of Common Stock for each fractional share.

NO
APPRAISAL RIGHTS

Under
Delaware law, our Stockholders are not entitled to appraisal rights in connection with the Reverse Stock Split.

DECREASE
IN AUTHORIZED COMMON STOCK

PURPOSE
AND EFFECT OF THE DECREASE IN AUTHORIZED COMMON STOCK

When
the availability of more shares of Common Stock for issuance, as a result of the Reverse Stock Split, allows the Company greater
flexibility in pursuing financing from investors, the Company’s existing shareholders
will have a potential dilutive effect on their equity and voting power. Such potential dilutive effect
also has contributed to a lack of investor interest in the Company and has made it difficult for the Company to attract new investors
and potential business candidates. Accordingly, our Board proposed the Decrease in Authorized Common Stock as one method
to attract business opportunities for the Company. Our Board believes that the Decrease in Authorized Common Stock could reduce
the potential dilutive effect by reducing the availability of new common shares for future issuance and could help generate interest
in the Company by investors and provide business opportunities. We have no current plans, proposals or arrangements
to engage in any corporate transactions that would require the issuance of additional securities made available pursuant to this
proposal.

The Decrease
in Authorized Common Stock shall not affect any rights, privileges or obligations with respect to the shares of Common Stock existing
prior to the Decrease in Authorized Common Stock, nor does it increase or decrease the market capitalization of the Company. The
Decrease in Authorized Common Stock is not intended as, and will not have the effect of, a “going private transaction”
under Rule 13e-3 of the Exchange Act. We will continue to be subject to the periodic reporting requirements of the Exchange Act.

WHEN
DECREASE IN AUTHORIZED COMMON STOCK WILL GO INTO EFFECT

The Decrease
in Authorized Common Stock will become effective on the date that we file the Certificate of Amendment to the Articles of Incorporation
of the Company (the “Amendment”) with the Secretary of State of the State of Delaware. We intend to file the
Amendment with the Secretary of State of the State of Delaware promptly after the twentieth (20th) day following the
date on which this Information Statement is mailed to the Stockholders.

We currently
expect to file the Amendment on or about November 22, 2013.

SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The
following table sets forth information known to the Company with respect to the beneficial ownership (as such term is defined
in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) of the outstanding common stock of the Company as of October
9, 2013 by: (1) each person known by the Company to beneficially own 5% or more of the Company’s outstanding common
stock; (2) each of the named executive officers as defined in Item 402(a)(3); (3) each of the Company’s directors;
and (4) all of the Company’s named executive officers and directors as a group. As of October 9, 2013, there were a
total of 448,378,661 shares of Common Stock and 1,000,000 shares of Series B Preferred Stock issued and outstanding. Each share
of Common Stock is entitled to one vote on matters on which holders of voting stock of the Company are eligible to vote. Each
shareoftheClassBConvertiblePreferred Stock
areentitledtoa number of votesdetermined at any time and from time to time determined by
dividing the number of then issued andoutstanding shares of the Corporation's common
stock byone million. The Class B Convertible Preferred Stock shall have a right to
vote on all matters presented or submitted to the Corporation’s stockholders for approval in pari passu with holders of
the Corporation’s common stock, and not as a separate class.

The Class
B Convertible Preferred Stock will convert in their entirety, simultaneously to equal one half (1/2) the amount of shares of common
stock outstanding on a fully diluted basis immediately prior to any Conversion. The Conversion shares will be issued pro rata
so that each holder of the Class B Convertible Preferred Stock will receive the appropriate number of shares of common stock equal
to their percentage ownership of their Class B Convertible Preferred Stock. For example if there are 45,000,000 shares of common
stock outstanding, on a fully diluted basis, prior to the conversion, the Class B Preferred Stock would convert to 22,500,000
shares of common stock in their entirety, and therefore if a Class B shareholder owned 100,000 shares of Class B Convertible Preferred
Stock, the shareholder would receive 2,250,000 shares of common stock.

The column
entitled “Percentage of Outstanding Common Stock” shows the percentage of voting common stock beneficially owned by
each listed party.

The number
of shares beneficially owned is determined under the rules promulgated by the SEC, and the information is not necessarily indicative
of beneficial ownership for any other purpose. Under those rules, beneficial ownership includes any shares as to which
a person or entity has sole or shared voting power or investment power plus any shares which such person or entity has
the right to acquire within sixty (60) days of October 9, 2013 through the exercise or conversion of any stock option, convertible
security, warrant or other right. Unless otherwise indicated, each person or entity named in the table has sole voting
power and investment power (or shares such power with that person’s spouse) with respect to all shares of capital stock
listed as owned by that person or entity.

(6)

Common
stock

Class
B Preferred Stock

Number
of

Percentage
of

Number
of

Percentage
of

Shares

Shares

Shares

Shares

Name
and Address

Beneficially
Owned

Beneficially
Owned (1)

Beneficially
Owned

Beneficially
Owned (1)

B.
Michael Friedman

407
East Fort Street, Suite 510

Detroit,
MI. 48226

18,740,000

4.17

%

700,000

70.0

%

Barry
Hollander

319
Clematis Street

Suite
400

West
Palm Beach, FL. 33401

690,745

.15

%

50,000

5.0

%

Ender
Company Assets

24
De Castro Street

Tortola
VG110

44,000,000

9.83

%

—

—

%

Phillip
Johnston (2)

26
King Street

St.Pacome,Quiebec,Canada
GOL3XO

—

—

%

250,000

25.0

%

Capital
Strategies Corp. (3)

26
King Street

St.
Pacome, Quebec,Canada G0L3X0

—

—

%

150,000

15.0

%

All
directors and

executive
officers as

19,430,745

4.33

%

750,000

75.0

%

a
group (2 persons)

(1)

Based
on a total of an aggregate of 448,378,661 shares of common stock outstanding and 1,000,000 shares of Series B Preferred Stock
outstanding.

(2)

Includes
150,000 shares of Series B Preferred Stock owned by Capital Strategies Corp.

(3)

Philip
Johnston is the sole shareholder of Capital Strategies and has voting power of the shares owned by Capital Strategies Corp.

(7)

ADDITIONAL
INFORMATION

We are
subject to the disclosure requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith, file reports,
information statements and other information, including annual and quarterly reports on Form 10-K and 10-Q, respectively, with
the Securities and Exchange Commission (the “SEC”). Reports and other information filed by the Company can be inspected
and copied at the public reference facilities maintained by the SEC at 100 F. Street, N.E., Washington DC 20549. Copies of such
material can also be obtained upon written request addressed to the SEC, Public Reference Section, 100 F. Street, N.E., Washington
DC 20549 at prescribed rates. In addition, the SEC maintains a web site on the Internet (http://www.sec.gov) that contains reports,
information statements and other information regarding issuers that file electronically with the SEC through the Electronic Data
Gathering, Analysis and Retrieval System.

The following
documents, as filed with the SEC by the Company, are incorporated herein by reference:

(1)

Annual
Report on Form 10-K for the fiscal year ended December 31, 2012, filed with the SEC on April 2, 2013;

(2)

Current
Report on Form 8-K, filed with the SEC on April 30, 2013;

(3)

Current
Report on Form 8-K, filed with the SEC on May 28, 2013.

(4)

Quarterly
Report on Form 10-Q for the period ended June 30, 2013, filed with the SEC on August 14, 2013;

You may
request a copy of these filings, at no cost, by writing MEDISWIPE INC. 407 East Fort Street, Suite 510 Detroit, MI. 48226 Attn:
B. Michael Friedman, CEO or telephoning the Company at 248-262-6850. Any statement contained in a document that is incorporated
by reference will be modified or superseded for all purposes to the extent that a statement contained in this Information Statement
(or in any other document that is subsequently filed with the SEC and incorporated by reference) modifies or is contrary to such
previous statement. Any statement so modified or superseded will not be deemed a part of this Information Statement except as
so modified or superseded.

DELIVERY
OF DOCUMENTS TO SECURITY HOLDERS SHARING AN ADDRESS

If hard
copies of the materials are requested, we will send only one Information Statement and other corporate mailings to stockholders
who share a single address unless we received contrary instructions from any stockholder at that address. This practice, known
as “householding,” is designed to reduce our printing and postage costs. However, the Company will deliver promptly
upon written or oral request a separate copy of the Information Statement to a stockholder at a shared address to which a single
copy of the Information Statement was delivered. You may make such a written or oral request by (a) sending a written notification
stating (i) your name, (ii) your shared address and (iii) the address to which the Company should direct the additional copy of
the Information Statement, to the Company at 407 East Fort Street, Suite 510 Detroit, MI. 48226Attn: B. Michael Friedman,
CEO or telephoning the Company at 248-262-6850.

If multiple
Stockholders sharing an address have received one copy of this Information Statement or any other corporate mailing and would
prefer the Company to mail each stockholder a separate copy of future mailings, you may mail notification to, or call the Company
at, its principal executive offices. Additionally, if current stockholders with a shared address received multiple copies of this
Information Statement or other corporate mailings and would prefer the Company to mail one copy of future mailings to stockholders
at the shared address, notification of such request may also be made by mail or telephone to the Company’s principal executive
offices.